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Adipose tissue expansion occurs by increasing the size of
existing adipocytes or by increasing the number of adipocytes
via adipogenesis. Adipose tissue dysfunction in obesity is asso-
ciated with adipocyte hypertrophy and impaired adipogenesis.
We recently demonstrated that deletion of the ubiquitin ligase
Siah2 is associated with enlarged adipocytes in lean or obese
mice. In this study, we find that adipogenesis is impaired in
3T3-L1 preadipocytes stably transfected with Siah2 shRNA and
that overexpression of Siah2 in non-precursor fibroblasts pro-
motes adipogenesis. In the 3T3-L1 model, loss of Siah2 is asso-
ciated with sustained -catenin expression post-induction, but
depletion of -catenin only partially restores PPAR expression
and adipocyte formation. Using wild-type and Siah2/ adipose
tissue and adipose stromal vascular cells, we observe that Siah2
influences the expression of several factors that control adipo-
genesis, including Wnt pathway genes, -catenin, Zfp432, and
Bmp-4. Consistent with increased -catenin levels in shSiah2
preadipocytes, Wnt10b is elevated in Siah2/ adipose tissue
and remains elevated in Siah2/ primary stromal cells after
addition of the induction mixture. However, addition of BMP-4
to Siah2/ stromal cells reduces Wnt10b expression, reduces
Zfp521 protein levels, and increases expression of Zfp423, a
transcriptional regulator of peroxisome proliferator-activated
receptor  expression that controls commitment to adipogene-
sis and is repressed by Zfp521. These results indicate that Siah2
acts upstream of BMP-4 to regulate factors that control the
commitment of adipocyte progenitors to an adipogenic path-
way. Our findings reveal an essential role for Siah2 in the early
events that signal undifferentiated progenitor cells to become
mature adipocytes.
Adipose tissue expansion in response to excess caloric intake
is central to storing the surplus energy as neutral lipids. How-
ever, excess adipose tissue is a risk factor for developing insulin
resistance and type 2 diabetes as the lipid storage capacity of the
adipose tissue is exceeded (1). The capacity to store lipids can be
increased in two ways: by increasing the size of existing adi-
pocytes (hypertrophy) and by recruiting stromal cells to form
new adipocytes (hyperplasia). It has been consistently observed
that adipocyte hypertrophy is associated with insulin resistance
(2, 3) and strongly linked with adipose tissue inflammation as
the limit of adipocyte expansion via hypertrophy is reached (4,
5). As macrophage-mediated removal of necrotic-like hyper-
trophied adipocytes progresses, new adipocytes are formed to
maintain lipid storage capacity in the remodeled adipose tissue
(5–7). The importance of adipocyte hyperplasia in maintaining
adipose tissue function has prompted interest in understanding
the factors controlling recruitment of resident adipose tissue
stromal cells (8) or bone marrow-derived progenitor cells (9) to
undergo adipogenesis.
The ubiquitin-proteasome system is well described as con-
trolling the proteolysis and activity of key regulatory proteins
that determine proliferation and differentiation of stem/pro-
genitor cells of neural, hematopoietic, and mesenchymal origin
(10 –12). The ubiquitin-proteasome system functions as a set of
highly ordered enzymes that activate and then transfer ubiqui-
tin to a target protein, leading to proteasome-mediated degra-
dation of the target protein or non-proteolytic regulation of the
activity of the target protein (13). The proteasomal degradation
of regulatory proteins required for commitment of mesenchy-
mal progenitor cells to osteogenesis has been described for
Wnt/-catenin (14) and bone morphogenetic proteins (15).
These pathways also regulate commitment to an adipogenic
lineage.
Wnt10b, Wnt10a, and Wnt6 inhibit adipogenesis and pro-
mote osteogenesis via -catenin mechanisms (16) that are
terminated by proteasomal degradation of -catenin (17). Con-
versely, Wnt5a promotes adipogenesis (18) and the degrada-
tion of -catenin (19). Bone morphogenetic protein 4 (BMP-4)2
is a member of the TGF superfamily of growth factors that
were initially identified as controlling bone formation (20).
Subsequent data established a role for the BMPs in develop-
ment of many tissues, including adipose tissue (21), where
BMP-4 promotes commitment of mesenchymal stem cells to
the adipocyte lineage in white adipose tissue (22–24). However,
the role of the ubiquitin-proteasome system in the recruitment
of mesenchymal stem cells to form adipocyte progenitor cells is
not well defined.
Our studies in the 3T3-L1 model of adipogenesis indicate
that the ubiquitin ligase Siah2 promotes adipogenesis (25).
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Moreover, adipocytes from Siah2/ (Siah2KO) mice tend to
be larger than wild-type adipocytes (26), suggesting that loss of
Siah2 affects the ability to form new adipocytes in vivo. Thus,
we investigated whether Siah2 affects adipogenesis via Wnt or
BMP-4 pathways using primary adipose tissue stromal cells
obtained from wild-type and Siah2KO mice. Here we report
evidence that Siah2 functions upstream of BMP-4 to regulate
commitment of adipose tissue stromal cells to the adipogenic
pathway.
Results
Siah2 Expression Promotes Adipogenesis—Our previous
experiments using Siah2 siRNA in preadipocytes indicated that
Siah2 is necessary for induction of adipogenesis (25). To con-
firm that result with more sustained reductions in Siah2 expres-
sion, we generated 3T3-L1 preadipocytes stably expressing
non-silencing (NS) shRNA or Siah2 shRNA, each linked to GFP
expression as a marker of transfection. Fig. 1A demonstrates
that loss of Siah2 prior to induction of adipogenesis suppresses
adipocyte formation, as assayed by neural lipid staining (Oil
Red O) compared with untransfected 3T3-L1 preadipocytes
(3T3-L1) or preadipocytes transfected with a non-silencing
shRNA. Fig. 1B shows that Siah2 is depleted in shSiah2-trans-
fected cells throughout the adipogenesis time course. In agree-
ment with our previous finding that Siah2 is up-regulated dur-
ing 3T3-L1 adipogenesis (25), Siah2 mRNA levels are increased
in untransfected and non-silencing shRNA-transfected 3T3-L1
cells during adipogenesis (Fig. 1B). Consistent with a substan-
tial reduction in lipid droplet formation in the absence of Siah2,
mRNA levels of transcription factors required for adipogenesis
(Pparg and Cebpa) (Fig. 1C) and markers of adipocyte forma-
tion (Adipoq, Fabp4, and Lpl) (Fig. 1D) are not up-regulated. To
further evaluate whether Siah2 contributes to preadipocyte
commitment, we ectopically expressed Siah2 in non-adipo-
genic NIH 3T3 fibroblasts. Ectopic expression of Siah2 stimu-
lates adipogenesis, but only in the presence of a PPAR ligand
(Fig. 1E, TZD). Gene expression of Pparg and the adipogenic
markers Fabp4 and Lpl on day 4 post-induction with overex-
pression of Siah2 is comparable with the levels obtained with
overexpression of PPAR both in the presence of rosiglitazone
(Fig. 1F). Although Siah2 stimulates PPAR gene expression
post-induction, ectopic overexpression of PPAR induces
FIGURE 1. Siah2 promotes adipogenesis in 3T3-L1 preadipocytes and non-precursor fibroblasts. A, 3T3-L1 preadipocytes did not undergo transfection
(3T3-L1) or were stably transfected with non-silencing shRNA or Siah2 shRNA co-expressing GFP and induced to undergo adipogenesis. Accumulation of
neutral lipids was detected using Oil Red O, and GFP was detected via fluorescence microscopy. B, Siah2 gene expression is up-regulated in untransfected and
NS shRNA-transfected cells and specifically reduced in shSiah2-transfected cells during induction of adipogenesis. C and D, mRNA levels of transcription factors
necessary for adipogenesis (C, Pparg and Cebpa) and late markers of adipogenesis (D; Adipoq, Fabp4, and Lpl) are not up-regulated in the absence of Siah2. E,
neutral lipid accumulation is detected using Oil Red O in non-precursor NIH3T3 fibroblasts induced to undergo adipogenesis with or without rosiglitazone (2.5
M, TZD) after ectopic expression of PPAR or Siah2. F, mRNA levels of markers of adipogenesis (Pparg, Fabp4, and Lpl) are up-regulated in non-precursor
fibroblasts with ectopic expression of Siah2. Gene expression was assayed using qRT-PCR. Statistical significance is compared with the corresponding day 0. *,
p  0.01.
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Siah2 gene expression prior to adding the adipogenic mixture
and rosiglitazone as a PPAR ligand.
Siah2 Regulates Expression of -Catenin during Adipo-
genesis—Stimulation of adipogenesis via up-regulation of
PPAR expression has the reciprocal effect of inhibiting osteo-
genesis via inhibition of -catenin (27, 28), a transcriptional
coactivator regulated by Wnt signaling that suppresses adipo-
genesis (16) and promotes osteoblast formation (29, 30). Acti-
vation of PPAR during adipogenesis inhibits -catenin activ-
ity by promoting proteasomal degradation of -catenin (17).
The absence of PPAR protein expression in shSiah2 preadi-
pocytes after treatment with the adipogenic mixture (Fig. 2B)
prompted us to ask whether impaired adipogenesis correlated
with increased -catenin levels. This possibility was supported
by experiments in HEK293 cells that found that non-canonical
Wnt5a-mediated degradation of -catenin involves Siah2 (19).
In our experiments, loss of Siah2 in preadipocytes increases
-catenin gene and protein (Fig. 2, A and B) expression during
FIGURE 2. Siah2-mediated regulation of -catenin expression does not directly account for the effect of Siah2 on adipogenesis. A, -catenin gene
expression was assayed prior to induction of adipogenesis (day 0) or 6 days post-induction in untransfected (3T3-L1), NS shRNA transfected and shSiah2-
transfected 3T3-L1 preadipocytes. B, -catenin and PPAR protein expression was assayed by Western blotting analysis. C, depletion of -catenin alone
(-catenin siRNA) or in combination with shSiah2 was confirmed using real-time qRT-PCR on day 6 post-induction. D, accumulation of neutral lipids was assayed
via Oil Red O staining on day 4 post-induction of Siah2-depleted or Siah2/-catenin-depleted 3T3-L1 preadipocytes. E, adipogenic markers were assayed on
days 0 and 4 post-induction in control (NS), -catenin, Siah2, or Siah2/-catenin-depleted 3T3-L1 preadipocytes. F, Siah2 mRNA expression was determined in
mature adipocytes and SVF cells isolated from visceral (epididymal white adipose tissue, eWAT) or subcutaneous (inguinal white adipose tissue, iWAT) fat
depots. G, Siah2 mRNA levels were determined during induction of adipogenesis in adherent stromal cells isolated from wild-type iWAT. Gene expression was
assayed using real-time qRT-PCR. Statistical significance was compared with corresponding day 0 (A, E, and G), non-silencing preadipocytes (C), or mature
adipocytes (F). #, p  0.05; *, p  0.01.
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adipogenesis. To determine whether elevated -catenin ex-
pression accounts for the effect of Siah2 depletion on adipogen-
esis, we depleted -catenin in the shSiah2 preadipocytes (Fig.
2C). Lipid accumulation (Oil Red O) is enhanced by reducing
-catenin expression in shSiah2 cells but does not return to the
levels observed when both Siah2 and -catenin are present (Fig.
2D). Expression of Pparg and other markers of adipocyte for-
mation (Adipoq, Fabp4, and Lpl) were slightly increased in the
Siah2, -catenin double deletion but significantly less than in
control cells (Fig. 2E). The failure of -catenin depletion to fully
restore adipocyte formation indicates that Siah2 functions
“upstream” of -catenin expression. Together with reduced
expression of the transcriptional regulators of adipogenesis
(Fig. 1C), the results suggest a role for Siah2 in determining
commitment of preadipocytes to undergo adipogenesis. Con-
sistent with that possibility, Siah2 mRNA is expressed in stro-
mal vascular fraction (SVF) cells and mature adipocytes iso-
lated from murine epididymal and inguinal adipose tissue (Fig.
2F). Moreover, the levels of Siah2 mRNA are 2-fold higher in
the inguinal SVF compared with adipocytes (Fig. 2F). When
primary cells obtained from the inguinal adipose tissue of wild-
type mice are induced to undergo adipogenesis ex vivo, Siah2
expression increases slightly on day 3 post-induction but is
below preinduction levels by day 7 post-induction (Fig. 2G).
Regulation of Wnt Pathway Genes by Siah2—As an indicator
of whether Siah2 influences commitment of adipose tissue
mesenchymal precursors to undergo adipogenesis, we focused
on the expression of Wnt10a, Wnt10b, Wnt6, and Wnt5a. Wnt
pathway genes are well described as inhibiting commitment to
the adipogenic pathway (16, 31) or, conversely, promoting adi-
pogenesis in the case of WNT5a (18). Wnt10a, Wnt10b, Wnt6,
and Wnt5a levels were determined in SVF cells isolated from
the inguinal adipose tissue of wild-type and Siah2KO mice. As
shown in Fig. 3A, Siah2 deletion is associated with substantially
higher levels of Wnt10b and Wnt6 and significant but small
increases for Wnt10a and Wnt5a. When the adherent popula-
tion of stromal cells is induced to undergo adipogenesis,
Wnt5a, Wnt6, and Wnt10a expression decreases, but Wnt10b
mRNA levels are unchanged in Siah2-deficient cells (Fig. 3B).
The correlation between loss of Siah2 and increased Wnt10b
expression implies that Siah2 affects adipogenic potential
via Wnt10b. To begin understanding whether regulation of
Wnt10b accounts for Siah2KO-mediated inhibition of adipo-
genesis, we first assayed the levels of Wisp-2, Bmp-4, and
Zfp423 as factors that interact with the Wnt pathway in adipose
tissue to regulate adipogenesis.
Siah2 Acts Upstream of BMP-4 during Adipogenesis—Wnt1-
inducible-signaling pathway protein 2 (WISP2) is a secreted
protein that is highly expressed in adipose tissue SVF cells (32).
WISP2 has been described as activating Wnt signaling (32–34)
and inhibiting both adipocyte commitment and adipogenesis
(32, 33). BMP-4 and Wisp2 activities intersect at regulation of
Zfp423 (32, 34), a transcriptional coactivator of PPAR that
influences preadipocyte conversion to adipocytes at least in
part by enhancing sensitivity to BMP-4 stimulation of adipo-
genesis (35). Zfp423 transcriptional coactivator function is
restrained when bound by WISP2 in the cytoplasm. The
Wisp2-Zfp423 complex is disrupted by BMP-4, allowing
Zfp423 to enter the nucleus (32).
Contrary to our expectations, we found that wisp2 expres-
sion is reduced in the inguinal adipose tissue of Siah2KO mice,
and expression of Bmp-4 and Zfp423 was also lower in the
absence of Siah2 (Fig. 4A). Expression of wisp2 is not regulated
by Siah2 during adipogenesis, whereas bmp-4 levels are signif-
icantly lower in the adherent stromal cell population of
Siah2KO compared with the wild type and are further reduced
when the cells are induced to undergo adipogenesis (Fig. 4B). In
addition, Zfp423 gene expression is significantly up-regulated
with adipogenesis in wild-type but unchanged in Siah2KO stro-
mal cells (Fig. 4B). Because reduced Bmp-4, but not Wisp2,
expression correlates with impaired adipogenic potential and
reduced Zfp423 levels in the Siah2KO cells, we asked whether
adding BMP-4 prior to induction could improve adipogenesis
in Siah2KO cells. When BMP-4 (40 ng/ml) is present prior to
induction of adipogenesis, the levels of Ppargamma, Fabp4, and
Lpl are substantially increased, indicating that BMP-4 overrides
inhibition of adipogenesis because of deletion of Siah2 (Fig. 4C).
This change is associated with down-regulation of Wnt10b, up-
FIGURE 3. Loss of Siah2 regulates Wnt expression in adipose tissue and during adipogenesis. A and B, gene expression of Wnt5a, Wnt6, Wnt10a, and
Wnt10b was assayed in inguinal adipose tissue SVF cells (A) or during induction of adipogenesis in adherent stromal cells isolated from wild-type and Siah2KO
inguinal adipose tissue (B). Gene expression was assayed using real-time qRT-PCR. Statistical significance compared with the corresponding wild type. #, p 
0.05; *, p  0.01.
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regulation of Zfp423, and a small but significant increase in
Wisp2 levels (Fig. 4C). To confirm that BMP-4 enhances adipo-
genesis in Siah2KO cells, lipid accumulation was visualized
using Oil Red O staining in wild-type cells or Siah2KO cells
induced to undergo adipogenesis in the absence or presence of
BMP-4. As shown in Fig. 4D, lipid droplets accumulate only
when Siah2KO cells are induced in the presence of BMP-4.
Siah2 Targets Zfp521 for Proteasomal Degradation—Siah2-
mediated regulation of Zfp423 mRNA expression suggests that
Siah2 functions to affect stability of a factor that controls tran-
scription of Zfp423. Zfp521 is a transcriptional regulator that
represses Zfp423 expression (36, 37) and acts to inhibit adipo-
genesis (37). Thus, we asked whether Zfp521 protein levels are
altered during induction of adipogenesis in stromal cells from
the inguinal adipose tissue of wild-type and Siah2KO mice. Fig.
5A shows that Zfp521 protein levels are increased prior to
induction (day 0 post-induction) in the absence of Siah2 com-
pared with the wild type and that Zfp521 levels increase during
induction of adipogenesis in Siah2KO cells in the absence of
BMP-4. When BMP-4 (40 ng/ml) is added 1 day prior to induc-
tion in Siah2KO cells, Zfp521 levels are substantially reduced by
day 2 post-induction and are comparable with the wild type by
day 4 post-induction. Experiments in vitro (Fig. 5B) demon-
strate that HA-tagged ZFP521 levels are substantially reduced
in the presence of FLAG-Siah2 but increased by proteasome
inhibition (epoxomicin) when expressed alone or in the pres-
ence of FLAG-Siah2, indicating that Siah2 increases protea-
somal degradation of Zfp521. MemCode staining (Fig. 5C) of
the nitrocellulose membrane corresponding to the Western
blot shown in Fig. 5B confirms equal loading of protein in each
lane. Taken together, our results indicate that Siah2 regulates
early steps in commitment to adipogenesis via regulation of
FIGURE 4. Siah2 acts upstream of BMP-4 to promote adipogenesis. A and B, Bmp-4, Wisp2, and Zfp423 gene expression was assayed in wild-type and
Siah2KO inguinal adipose tissue (A) or prior to induction of adipogenesis in wild-type and Siah2KO primary inguinal adherent stromal cells (MDI) and on day
4 post induction (MDI) (B). C, markers of adipogenesis (Pparg, Fabp4, and Lpl), Wnt10b, Wisp2, and Zfp423 gene expression were assayed during adipogenesis
in the absence or presence of 40 ng/ml BMP-4. D, Oil Red O staining of neutral lipid accumulation on day 4 post-induction of adipogenesis in wild-type and
Siah2KO stromal cells. Siah2KO stromal cells were incubated in the absence (Siah2KO/BMP-4) or presence of 40 ng/ml BMP-4 (Siah2KO/BMP-4). Statistical
significance of Siah2KO was compared with the wild type (A), wild-type MDI (B), or the corresponding day 0 (C). #, p  0.05; *, p  0.01; ^, p  0.01 compared
with MDI, day 0.
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Zfp521 protein levels in a BMP-4-dependent manner to pro-
mote Zfp423 mRNA expression (Fig. 5D).
Discussion
Identifying the factors that participate in converting adi-
pocyte stromal cells to mature adipocytes is fundamentally
important to understanding the expansion of adipose tissue in
obesity. Adipocytes in the visceral and subcutaneous adipose
depots of lean or obese Siah2KO mice are hypertrophied, con-
sistent with impaired adipogenesis in vivo that is related to loss
of Siah2 (26). Although adipogenesis is impaired, both lean and
obese Siah2KO mice were more insulin-sensitive compared
with the wild type. Along with other studies showing that
enlarged adipocytes can be associated with metabolic health
(38), these results indicate that sufficient lipid storage capacity
can occur in adipose tissue independent of a robust adipogenic
response to energy challenges.
In this study, we investigated the role of Siah2 in adipogene-
sis. We found that the ubiquitin ligase Siah2 promotes adipo-
genesis by influencing early steps in commitment to the adipo-
genic pathway via regulation of Bmp-4 and Zfp423 expression
and Zfp521 protein stability. Our previous experiments using
the 3T3-L1 model of adipogenesis showed that Siah2 mRNA
levels are low and that Siah2 protein is not detected in commit-
ted preadipocytes but increase during adipogenesis (25). This
suggested that Siah2 expression is stimulated upon induction of
adipogenesis and contributes to adipogenesis after progenitor
cells are committed to the adipogenic pathway. However,
induction of adipogenesis in adipose tissue stromal vascular
cells argues for an earlier role for Siah2 in adipogenesis. Siah2
levels are higher in stromal vascular cells than in mature adi-
pocytes, and Siah2 levels are only transiently up-regulated dur-
ing adipogenesis of the adherent stromal cells. Impaired adipo-
genesis in the Siah2KO stromal cells correlates with reduced
Bmp-4 levels and is overcome by ectopic expression of BMP-4,
a bone morphogenetic protein that regulates commitment of
progenitor cells to an adipogenic lineage (23). Thus, it is likely
that Siah2 is found in stromal vascular cell types other than
committed preadipocytes and that Siah2 affects processes
upstream of BMP-4 to determine adipogenic potential.
Decreased expression of Bmp-4 in Siah2KO adipose tissue
further supports the ex vivo data implicating Siah2 in promot-
ing commitment of adipose stromal cells to undergo adipogen-
esis. BMP-4-mediated down-regulation of Wnt10b coupled
with reduced expression of Wisp2 independent of Siah2 or
BMP-4 upon induction of adipogenesis in Siah2KO stromal
cells suggests that Wnt signaling does not directly account for
the effect of Siah2 on adipogenic potential. However, Zfp423
expression is attenuated in the absence of Siah2 both in vivo and
ex vivo, and restoration of adipogenesis by BMP-4 in Siah2KO
stromal cells is associated with robust up-regulation of Zfp423.
Zfp423 regulates commitment of stromal vascular cells to the
adipogenic pathway in part via increasing sensitivity to BMP-4
signaling to promote adipogenesis (35). Zfp423 is also reported
to link BMP-4 and Notch signaling (39), indicating a complex
relationship between Zfp423 and BMP-4 in cell differentiation
that may be regulated by Siah2. Our findings indicate that
Zfp521, a paralog of Zfp423 that acts as a transcriptional repres-
sor of Zfp423 (36, 37), is a likely target of Siah2 activity and that
Siah2-mediated degradation of Zfp521 may function to dere-
press Zfp423 expression. Finally, down-regulation of Zfp521
protein by BMP-4 during induction of adipogenesis in Siah2KO
stromal cells positions BMP-4 as mediating the effect of Siah2
on Zfp521 protein levels and, subsequently, Zfp423 expression.
Although enzymes of the ubiquitin-proteasome system are
well described as regulating proliferation and differentiation of
stem and progenitor cells, the focus has largely been on under-
standing the role of ubiquitin-proteasome system enzymes
in regulating pluripotency and reprogramming in embryonic
stem cells (10, 40). However, evidence is accumulating that
ubiquitin system enzymes control the stability and activity of a
range of proteins that regulate terminal adipogenesis (41– 43).
Given the reciprocal nature of adipocyte and osteoblast forma-
tion, evidence that the ubiquitin-proteasome system affects
bone formation via regulation of bmp-2 expression (15) sup-
FIGURE 5. Siah2 regulates Zfp521 protein levels. A, Zfp521 protein levels
were assayed during induction of adipogenesis in stromal cells isolated from
wild-type and Siah2KO inguinal adipose tissue. Control Zfp521 is untagged
mouse Zfp521 transiently expressed in HEK293 cells. Where indicated, BMP-4
(40 ng/ml) was added 2 days prior to induction of adipogenesis. B, HEK293
cells were transiently transfected with HA-Zfp521 and pcDNA3.1 or HA-
Zfp521 and FLAG-Siah2 and treated with the proteasome inhibitor epoxomi-
cin (1 M) as indicated. The top panel is a short film exposure, and the bottom
panel is a long film exposure to detect HA-Zfp521. Protein levels (A and B)
were assayed by Western blotting analysis. C, MemCode staining of the total
protein present in B. D, schematic depicting Siah2-mediated commitment to
adipogenesis via regulation of a pathway that involves BMP-4, Zfp521, and
Zfp423 expression in adipose tissue stromal vascular cells.
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ports a role for ubiquitin system enzymes in determining
whether mesenchymal progenitor cells are recruited to
undergo adipogenesis. A more specific link to Siah2 is found in
studies that show that c-Cbl, a cytoplasmic ubiquitin ligase that
regulates osteoblast proliferation and differentiation (44), also
partners with Siah2 to control signaling events in cell prolifer-
ation and differentiation (45, 46).
This study places Siah2 as an upstream regulation of zfp423
gene expression and indicates that Siah2 influences Zfp423
gene expression via regulation of Bmp-4 expression and Zfp521
protein stability. Generally, our results show that the mecha-
nisms linking Zfp423 and BMP-4-mediated regulation of adi-
pogenesis extend to control of Zfp423 and Bmp-4 gene expres-
sion. Our results clearly place the ubiquitin ligase Siah2 as a
factor that mediates the relationship between Bmp-4 and
Zfp423 expression in determining commitment of adipose
stromal cells to an adipogenic lineage.
Experimental Procedures
Animal Experiments—Wild-type and global Siah2/
(Siah2KO) C57BL/6J male mice were housed with a 12-h light-
dark cycle at 24 °C. All animal experiments were carried out in
accordance with the Guide for the Care and Use of Laboratory
Animals and approved by the Pennington Biomedical Research
Center Animal Care and Use Committee (protocol 876). At
4 – 8 weeks of age, the mice were euthanized between 8 –11
a.m., and the inguinal and epididymal adipose tissue was
harvested for whole tissue analysis or isolating SVF cells and
mature adipocytes.
Cell Culture—Murine 3T3-L1 preadipocytes were plated and
grown to 2 days post-confluence in DMEM high-glucose with
10% bovine serum, 100 units of penicillin/100 g of streptomy-
cin. The medium was changed every 48 h. Cells were induced to
differentiate by changing the medium to DMEM high-glucose
containing a standard induction mixture of 10% FBS, 0.5 mM
isobutylmethylxanthine (IBMX), 1 M dexamethasone, 1.7 M
insulin (MDI), and 100 units of penicillin/100 g of streptomy-
cin. After 48 h, this medium was replaced with DMEM high-
glucose supplemented with 10% FBS, and cells were maintained
in this medium. The NIH 3T3 fibroblast cell lines (ATCC)
ectopically expressing Siah2 or PPAR were induced to differ-
entiate with standard induction mixture in the presence or
absence of rosiglitazone (TZD, 2.5 M). HEK293 cells were
maintained in DMEM high-glucose with 10% FBS, 100 units of
penicillin/100 g of streptomycin.
Adipose tissue obtained from wild-type or Siah2KO mice
was minced and suspended in PBS supplemented with 0.1%
bovine serum and 0.1% collagenase type I (Worthington) pre-
warmed to 37 °C at 10 ml/2 g of tissue. The tissue was incubated
in a shaking water bath at 37 °C for 1 h and centrifuged at 450 
g for 5 min at room temperature. Mature adipocytes from both
inguinal and epididymal fat pads were collected from the super-
natant and processed for RNA isolation. The pelleted SVF cells
from both fat pads were also processed for RNA isolation. The
SVF cells from the inguinal adipose tissue were resuspended in
stromal medium (DMEM/Ham’s F-12 medium, 15% FBS, 100
units of penicillin/100 g of streptomycin), plated, and main-
tained as described previously (47). When the cells were
80 –90% confluent, the stromal medium was exchanged for dif-
ferentiation medium (DMEM/Ham’s F-12 medium with 3%
FBS, 0.5 mM IBMX, 33 M biotin, 17 M pantothenate, 1 M
insulin, 1 M dexamethasone, 2.5 M rosiglitazone, and 100
units of penicillin/100 g of streptomycin). After 3 days, the
medium was exchanged for maintenance medium that was
identical to the differentiation medium except that IBMX and
rosiglitazone were deleted. BMP-4 (Life Technologies, 40
ng/ml) was added to the medium 5 days prior to induction.
Generating Stable Cell Lines—Retrovirus-mediated stable
expression of shRNA targeting Siah2 (SMARTvector lentiviral
shRNA) or a non-silencing control hairpin sequence containing
the TurboGFP marker in the pGIPZ vector (Dharmacon) was
generated in 3T3-L1 preadipocytes according to the instruc-
tions of the manufacturer. Selection of preadipocytes contain-
ing the desired shRNA was carried out using puromycin (2.5
g/ml) over 2 weeks. -Catenin was depleted in the non-silenc-
ing pGIPZ and pGIPZ-shSiah 3T3-L1 preadipocytes via reverse
transfection (48) using siRNA targeting -catenin (Dharmacon
SMARTpool On-Targetplus siRNA). The preadipocytes were
transfected 1 day prior to inducing the cells to undergo adipo-
genesis. Depletion of target genes was confirmed using qRT-
PCR. To overexpress Siah2 in NIH3T3 fibroblasts, Siah2 cDNA
was amplified via PCR to contain a 5 EcoR1 restriction site
and a 3 Sal1 restriction site. The PCR product was purified
(Qiagen MiniElute PCR purification) and inserted into the
pBabePuro vector (Addgene) using site-directed mutagene-
sis (Stratagene QuikChange). The sequence was confirmed
by dideoxy sequencing prior to transfection of pBabePuro-
Siah2 into NIH3T3 fibroblasts as described previously (49).
Transient Transfection of HA-Zfp521 and FLAG-Siah2—
Mouse Zfp521 cDNA was obtained from OriGene (TrueClone
cDNA), and the HA epitope tag was inserted after the start
codon using site-directed mutagenesis (Stratagene Quik-
Change II) and confirmed by dideoxy sequencing as described
previously (25). HEK293 cells were grown to 40 –70% conflu-
ence, and transient transfections were carried out using a total
of 2 g of cDNA/well and Polyfect according to the instructions
of the manufacturer (Qiagen). The cells were transfected with
HA-Zfp521 and pcDNA3.1 or HA-Zfp521 and FLAG-Siah2.
Forty-eight hours after transfection, the cells were treated with
vehicle control (DMSO) or epoxomicin (1 M), and whole cell
extracts were harvested 4 h later.
Oil Red O Staining—Oil Red O staining was performed as
described by Green and Kehinde (50).
Quantitative PCR—Total RNA was reverse-transcribed (200
ng of RNA) using Multiscribe reverse transcriptase (Applied
Biosystems) with random primers at 37 °C for 2 h. Real-time
PCR was performed with TaqMan chemistry using the 7900
real-time PCR system and universal cycling conditions (50 °C
for 2 min; 95 °C for 10 min and 40 cycles of 95 °C for 15 s and
60 °C for 1 min, followed by 95 °C for 15 s, 60 °C for 15 s, and
95 °C for 15 s). The results were normalized to cyclophilin B or
ubiquitin B mRNA levels and analyzed using the 2CT
method.
Preparation of Whole Cell Extracts and Immunoblotting—
Whole cell extracts were prepared by homogenizing in 50 mM
Tris/Cl (pH 7.4) with 150 mM NaCl, 1 mM EDTA, 1% Igepal CA
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630, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM N-ethylma-
leimide, protease inhibitors (1 mM PMSF, 10 g/ml aprotinin, 1
g/ml pepstatin, and 5 g/ml leupeptin), and phosphatase
inhibitor (2 mM sodium orthovanadate). The samples were
centrifuged at 14,000  g for 10 min at 4 °C, and protein con-
centrations were determined by BCA assay (Thermo Fisher
Scientific).
Gel Electrophoresis and Immunoblotting—Proteins were sep-
arated in polyacrylamide (National Diagnostics) gels contain-
ing SDS and transferred to nitrocellulose (Bio-Rad). Following
transfer, the membrane was blocked in 4% milk in 25 mM
Tris/Cl (pH 8.0) with 150 mM NaCl, 0.1% Tween 20 (TBS-T) for
1 h at room temperature. The membranes were incubated with
antibodies against PPAR (Santa Cruz Biotechnology, sc-7273,
1:200; Abcam, 19481, 1:500), -catenin (Bethyl Laboratories,
A302-012A-M, 1:1000), Zfp521 (ProSci, 6859, 1:1000), HA
epitope tag (BioLegend, 901513, 1:2000), and FLAG epitope tag
(Sigma, F1804, 1:500) for 1–2 h at room temperature. The
results were visualized with HRP-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories) and enhanced
chemiluminescence (Thermo Fisher/Pierce). Equal loading was
determined using MemCode (Thermo Fisher Scientific) stain-
ing of the nitrocellulose membrane.
Statistical Analysis—Statistical significance was determined
using an unpaired two-tailed t test. GraphPad Prism 5 software
was used for statistical analyses. Adipose tissue data (Fig. 4A)
were obtained from 4 mice/group, and adipogenesis in primary
SVF cells was carried out in pooled samples from three to four
mice and repeated at least twice. Experiments in the 3T3-L1
adipocytes and HEK293 cells were repeated at least twice for a
minimum of three replicates. All technical replicates were car-
ried out in triplicate. Variability was expressed as the mean 
S.D.
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